---
url: https://www.servicesaustralia.gov.au/acromegaly
title: Acromegaly - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:39:56.893Z
source: servicesaustralia.gov.au
---
# Acromegaly

The PBS subsidises pasireotide and pegvisomant for patients with acromegaly.

## on this page

-   [Patient eligibility](#a1)
-   [Section 100 arrangements](#a2)
-   [Authority applications](#a3)
-   [More information](#a4)

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with pasireotide and pegvisomant under the _National Health Act 1953_, section 100 for patients with acromegaly.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant criteria in the restrictions.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/) on the PBS website lists restrictions for prescribing pasireotide and pegvisomant.

## Section 100 arrangements

### pasireotide and pegvisomant

These items are only PBS-subsidised for non-admitted patients, day admitted patients, or patients on discharge who are attending:

-   an approved private hospital
-   a public hospital.

These items aren’t PBS-subsidised for public hospital in-patients. You must include the hospital name and provider number on the authority application form.

## Authority applications

### Applying for initial treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20).

Applications for initial authority approval to prescribe PBS-subsidised pasireotide or pegvisomant to treat acromegaly can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications for pasireotide must include:

-   details of the proposed prescription or prescriptions
-   the completed [acromegaly - pasireotide - initial authority application form](/pb181?context=20)
-   relevant attachments.

All written applications for pegvisomant must include:

-   details of the proposed prescription or prescriptions
-   the completed [acromegaly - pegvisomant - initial authority application form](/pb225?context=20)
-   relevant attachments.

### Applying for continuing treatment

Applications for continuing authority approval to prescribe PBS-subsidised pasireotide or pegvisomant to treat acromegaly can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.
